Bio Therapeutic Drugs Company Investment Opportunity in Sydney, Australia
Established | 1-5 year(s) |
Employees | 2 - 5 |
Legal Entity | Private Limited Company |
Reported Sales | Nil |
Run Rate Sales | Nil |
EBITDA Margin | Nil |
Industries | Bio Therapeutic Drugs |
Locations | Sydney |
Local Time | 8:25 AM Australia / Sydney |
Listed By | Business Owner / Director |
Status | Active |
- Developed as an image-guided intra-disc administration under local anesthesia, ensuring precision and effectiveness in the therapeutic process.
- A therapeutic candidate for the regeneration of spinal intervertebral discs in patients with debilitating degenerative disc conditions.
- Induces the mobilization and differentiation of stem cells, leading to de novo regeneration of intervertebral discs and stabilization of the affected spine.
- Backed by a compelling biological rationale and a robust preclinical data set, demonstrating a strong proof of concept.
- Cure back pain with personalized, targeted, regenerative therapy via a non-invasive injection directly into the disc.
- Offers a cost-effective and quick procedure, aiming to enhance the quality of life for patients.
- Positioned in the $300 billion back pain industry, addressing a significant market need.
- Great investment opportunity at the seed stage, with RDTI registration in Australia reflecting a commitment to research and development.
- Administered as a convenient day procedure service, either in a radiology suite or a day procedure facility.
- Founded by individuals with decades of experience in the industry.
New IP generation via contracted university research.
-
Earlier than 15 daysManaging Director, Aviation, Aerospace &Defence, Hyderabad, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysChief Technical Officer, London, Commercial Real Estate Broker connected with the Business